Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bakker Juliet Tammenoms currently holds 23,284 shares of Aimmune Therapeutics, Inc. (AIMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bakker Juliet Tammenoms has been a net buyer of AIMT stock. They have purchased $55.4M and sold $50.2M worth of shares.
Bakker Juliet Tammenoms's most recent insider trade was on Jun 2, 2026, when they sold 7,838 shares at $0.00 per share.
Bakker Juliet Tammenoms serves as Executive at Aimmune Therapeutics, Inc. (AIMT). They have executed 77 insider transactions totaling $105.7M over their tenure at the company.
Bakker Juliet Tammenoms holds the position of Executive at Aimmune Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Bakker Juliet Tammenoms has shown a buying trading pattern, with $55.4M in total purchases and $50.2M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Bakker Juliet Tammenoms was on Nov 15, 2023, when they sold $10.9M worth of RXST shares. This transaction involved 400,000 shares at $27.20 per share.
Bakker Juliet Tammenoms currently owns 23,284 shares of Aimmune Therapeutics, Inc. (AIMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bakker Juliet Tammenoms's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bakker Juliet Tammenoms has 77 Form 4 filings on record as an insider at Aimmune Therapeutics, Inc..
Set alerts for Bakker Juliet Tammenoms and 40,000+ other insiders.